Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma
Clinical trial NCT05717153 · RECRUITING
Trial details
- NCT number
- NCT05717153
- Sponsor
- Mayo Clinic
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2027-01-15
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.